The global Follicle Stimulating Hormone (FSH) Injections market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
The fertility preservation and infertility treatment market has witnessed significant growth in recent years, driven by factors such as increasing infertility rates, delayed pregnancies, advancements in assisted reproductive technologies (ART), and growing awareness. Fertility preservation technologies, including egg freezing and sperm banking, have gained popularity among individuals seeking to preserve their reproductive potential. In the infertility treatment segment, in vitro fertilization (IVF), intrauterine insemination (IUI), and other ART procedures have become mainstream options. Future developments are anticipated in areas such as personalized medicine, gene editing technologies, and improved success rates in ART procedures. The market is likely to see ongoing advancements, innovations, and collaborations aimed at addressing infertility challenges and expanding the range of options available to individuals and couples.
Follicle Stimulating Hormone (FSH) injections are pharmaceutical preparations containing the hormone FSH, a crucial component in the regulation of reproductive processes. FSH is produced by the pituitary gland and plays a key role in the stimulation of ovarian follicles in females and sperm production in males. FSH injections are commonly used in assisted reproductive technologies, such as in vitro fertilization (IVF), to enhance the development and maturation of multiple follicles in the ovaries. In fertility treatments, these injections help regulate and stimulate the ovaries to produce more eggs, increasing the chances of successful fertilization and pregnancy.
Human follicle stimulating hormone (FSH) includes urinary human follicle stimulating hormone (uFSH) and recombinant FSH (rFSH). According to expert consensus, recombinant follicle-stimulating hormone is available in two dosage forms: powder injection and water injection.
This report studies the global Follicle Stimulating Hormone (FSH) Injections production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Follicle Stimulating Hormone (FSH) Injections, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Follicle Stimulating Hormone (FSH) Injections that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Follicle Stimulating Hormone (FSH) Injections total production and demand, 2019-2030, (K Units)
Global Follicle Stimulating Hormone (FSH) Injections total production value, 2019-2030, (USD Million)
Global Follicle Stimulating Hormone (FSH) Injections production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Follicle Stimulating Hormone (FSH) Injections consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Follicle Stimulating Hormone (FSH) Injections domestic production, consumption, key domestic manufacturers and share
Global Follicle Stimulating Hormone (FSH) Injections production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Follicle Stimulating Hormone (FSH) Injections production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Follicle Stimulating Hormone (FSH) Injections production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Follicle Stimulating Hormone (FSH) Injections market based on the following parameters 鈥� company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gonal-F (Merck), Follistim (Organon), Bravelle (Ferring), Menopur (Ferring), Fostimon (IBSA), Puregon (Organon), BEMFOLA (Gedeon Richter), Follitrope (LG Chem) and Livzon, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Follicle Stimulating Hormone (FSH) Injections market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Follicle Stimulating Hormone (FSH) Injections Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Follicle Stimulating Hormone (FSH) Injections Market, Segmentation by Type
by Injection Type
Powder
Liquid
by Source of Ingredients
Recombinant FSH (rFSH)
Urinary FSH (uFSH)
Global Follicle Stimulating Hormone (FSH) Injections Market, Segmentation by Application
IVF and Embryo Transfer
Infertility Treatment
Companies Profiled:
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
Livzon
GenSci
Key Questions Answered
1. How big is the global Follicle Stimulating Hormone (FSH) Injections market?
2. What is the demand of the global Follicle Stimulating Hormone (FSH) Injections market?
3. What is the year over year growth of the global Follicle Stimulating Hormone (FSH) Injections market?
4. What is the production and production value of the global Follicle Stimulating Hormone (FSH) Injections market?
5. Who are the key producers in the global Follicle Stimulating Hormone (FSH) Injections market?
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Supply Summary
1.1 Follicle Stimulating Hormone (FSH) Injections Introduction
1.2 World Follicle Stimulating Hormone (FSH) Injections Supply & Forecast
1.2.1 World Follicle Stimulating Hormone (FSH) Injections Production Value (2019 & 2023 & 2030)
1.2.2 World Follicle Stimulating Hormone (FSH) Injections Production (2019-2030)
1.2.3 World Follicle Stimulating Hormone (FSH) Injections Pricing Trends (2019-2030)
1.3 World Follicle Stimulating Hormone (FSH) Injections Production by Region (Based on Production Site)
1.3.1 World Follicle Stimulating Hormone (FSH) Injections Production Value by Region (2019-2030)
1.3.2 World Follicle Stimulating Hormone (FSH) Injections Production by Region (2019-2030)
1.3.3 World Follicle Stimulating Hormone (FSH) Injections Average Price by Region (2019-2030)
1.3.4 North America Follicle Stimulating Hormone (FSH) Injections Production (2019-2030)
1.3.5 Europe Follicle Stimulating Hormone (FSH) Injections Production (2019-2030)
1.3.6 China Follicle Stimulating Hormone (FSH) Injections Production (2019-2030)
1.3.7 Japan Follicle Stimulating Hormone (FSH) Injections Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Follicle Stimulating Hormone (FSH) Injections Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Follicle Stimulating Hormone (FSH) Injections Major Market Trends
2 Demand Summary
2.1 World Follicle Stimulating Hormone (FSH) Injections Demand (2019-2030)
2.2 World Follicle Stimulating Hormone (FSH) Injections Consumption by Region
2.2.1 World Follicle Stimulating Hormone (FSH) Injections Consumption by Region (2019-2024)
2.2.2 World Follicle Stimulating Hormone (FSH) Injections Consumption Forecast by Region (2025-2030)
2.3 United States Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.4 China Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.5 Europe Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.6 Japan Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.7 South Korea Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.8 ASEAN Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
2.9 India Follicle Stimulating Hormone (FSH) Injections Consumption (2019-2030)
3 World Follicle Stimulating Hormone (FSH) Injections Manufacturers Competitive Analysis
3.1 World Follicle Stimulating Hormone (FSH) Injections Production Value by Manufacturer (2019-2024)
3.2 World Follicle Stimulating Hormone (FSH) Injections Production by Manufacturer (2019-2024)
3.3 World Follicle Stimulating Hormone (FSH) Injections Average Price by Manufacturer (2019-2024)
3.4 Follicle Stimulating Hormone (FSH) Injections Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Follicle Stimulating Hormone (FSH) Injections Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Follicle Stimulating Hormone (FSH) Injections in 2023
3.5.3 Global Concentration Ratios (CR8) for Follicle Stimulating Hormone (FSH) Injections in 2023
3.6 Follicle Stimulating Hormone (FSH) Injections Market: Overall Company Footprint Analysis
3.6.1 Follicle Stimulating Hormone (FSH) Injections Market: Region Footprint
3.6.2 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Type Footprint
3.6.3 Follicle Stimulating Hormone (FSH) Injections Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 United States VS China VS Rest of the World
4.1 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Value Comparison
4.1.1 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Comparison
4.2.1 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Follicle Stimulating Hormone (FSH) Injections Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Follicle Stimulating Hormone (FSH) Injections Consumption Comparison
4.3.1 United States VS China: Follicle Stimulating Hormone (FSH) Injections Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Follicle Stimulating Hormone (FSH) Injections Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Follicle Stimulating Hormone (FSH) Injections Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Follicle Stimulating Hormone (FSH) Injections Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production Value (2019-2024)
4.4.3 United States Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production (2019-2024)
4.5 China Based Follicle Stimulating Hormone (FSH) Injections Manufacturers and Market Share
4.5.1 China Based Follicle Stimulating Hormone (FSH) Injections Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production Value (2019-2024)
4.5.3 China Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production (2019-2024)
4.6 Rest of World Based Follicle Stimulating Hormone (FSH) Injections Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Follicle Stimulating Hormone (FSH) Injections Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Follicle Stimulating Hormone (FSH) Injections Production (2019-2024)
5 Market Analysis by Type
5.1 World Follicle Stimulating Hormone (FSH) Injections Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Powder
5.2.2 Liquid
5.3 Market Segment by Type
5.3.1 World Follicle Stimulating Hormone (FSH) Injections Production by Type (2019-2030)
5.3.2 World Follicle Stimulating Hormone (FSH) Injections Production Value by Type (2019-2030)
5.3.3 World Follicle Stimulating Hormone (FSH) Injections Average Price by Type (2019-2030)
6 Market Analysis by Application
6.1 World Follicle Stimulating Hormone (FSH) Injections Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 IVF and Embryo Transfer
6.2.2 Infertility Treatment
6.3 Market Segment by Application
6.3.1 World Follicle Stimulating Hormone (FSH) Injections Production by Application (2019-2030)
6.3.2 World Follicle Stimulating Hormone (FSH) Injections Production Value by Application (2019-2030)
6.3.3 World Follicle Stimulating Hormone (FSH) Injections Average Price by Application (2019-2030)
7 Company Profiles
7.1 Gonal-F (Merck)
7.1.1 Gonal-F (Merck) Details
7.1.2 Gonal-F (Merck) Major Business
7.1.3 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.1.4 Gonal-F (Merck) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Gonal-F (Merck) Recent Developments/Updates
7.1.6 Gonal-F (Merck) Competitive Strengths & Weaknesses
7.2 Follistim (Organon)
7.2.1 Follistim (Organon) Details
7.2.2 Follistim (Organon) Major Business
7.2.3 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.2.4 Follistim (Organon) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Follistim (Organon) Recent Developments/Updates
7.2.6 Follistim (Organon) Competitive Strengths & Weaknesses
7.3 Bravelle (Ferring)
7.3.1 Bravelle (Ferring) Details
7.3.2 Bravelle (Ferring) Major Business
7.3.3 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.3.4 Bravelle (Ferring) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bravelle (Ferring) Recent Developments/Updates
7.3.6 Bravelle (Ferring) Competitive Strengths & Weaknesses
7.4 Menopur (Ferring)
7.4.1 Menopur (Ferring) Details
7.4.2 Menopur (Ferring) Major Business
7.4.3 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.4.4 Menopur (Ferring) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Menopur (Ferring) Recent Developments/Updates
7.4.6 Menopur (Ferring) Competitive Strengths & Weaknesses
7.5 Fostimon (IBSA)
7.5.1 Fostimon (IBSA) Details
7.5.2 Fostimon (IBSA) Major Business
7.5.3 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.5.4 Fostimon (IBSA) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Fostimon (IBSA) Recent Developments/Updates
7.5.6 Fostimon (IBSA) Competitive Strengths & Weaknesses
7.6 Puregon (Organon)
7.6.1 Puregon (Organon) Details
7.6.2 Puregon (Organon) Major Business
7.6.3 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.6.4 Puregon (Organon) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Puregon (Organon) Recent Developments/Updates
7.6.6 Puregon (Organon) Competitive Strengths & Weaknesses
7.7 BEMFOLA (Gedeon Richter)
7.7.1 BEMFOLA (Gedeon Richter) Details
7.7.2 BEMFOLA (Gedeon Richter) Major Business
7.7.3 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.7.4 BEMFOLA (Gedeon Richter) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 BEMFOLA (Gedeon Richter) Recent Developments/Updates
7.7.6 BEMFOLA (Gedeon Richter) Competitive Strengths & Weaknesses
7.8 Follitrope (LG Chem)
7.8.1 Follitrope (LG Chem) Details
7.8.2 Follitrope (LG Chem) Major Business
7.8.3 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Product and Services
7.8.4 Follitrope (LG Chem) Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Follitrope (LG Chem) Recent Developments/Updates
7.8.6 Follitrope (LG Chem) Competitive Strengths & Weaknesses
7.9 Livzon
7.9.1 Livzon Details
7.9.2 Livzon Major Business
7.9.3 Livzon Follicle Stimulating Hormone (FSH) Injections Product and Services
7.9.4 Livzon Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Livzon Recent Developments/Updates
7.9.6 Livzon Competitive Strengths & Weaknesses
7.10 GenSci
7.10.1 GenSci Details
7.10.2 GenSci Major Business
7.10.3 GenSci Follicle Stimulating Hormone (FSH) Injections Product and Services
7.10.4 GenSci Follicle Stimulating Hormone (FSH) Injections Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 GenSci Recent Developments/Updates
7.10.6 GenSci Competitive Strengths & Weaknesses
8 Industry Chain Analysis
8.1 Follicle Stimulating Hormone (FSH) Injections Industry Chain
8.2 Follicle Stimulating Hormone (FSH) Injections Upstream Analysis
8.2.1 Follicle Stimulating Hormone (FSH) Injections Core Raw Materials
8.2.2 Main Manufacturers of Follicle Stimulating Hormone (FSH) Injections Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Follicle Stimulating Hormone (FSH) Injections Production Mode
8.6 Follicle Stimulating Hormone (FSH) Injections Procurement Model
8.7 Follicle Stimulating Hormone (FSH) Injections Industry Sales Model and Sales Channels
8.7.1 Follicle Stimulating Hormone (FSH) Injections Sales Model
8.7.2 Follicle Stimulating Hormone (FSH) Injections Typical Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Gonal-F (Merck)
Follistim (Organon)
Bravelle (Ferring)
Menopur (Ferring)
Fostimon (IBSA)
Puregon (Organon)
BEMFOLA (Gedeon Richter)
Follitrope (LG Chem)
Livzon
GenSci
听
听
*If Applicable.
